CADgene: a comprehensive database for coronary artery disease genes by Liu, Hui et al.
CADgene: a comprehensive database for
coronary artery disease genes
Hui Liu
1, Wei Liu
2, Yifang Liao
2, Long Cheng
2, Qian Liu
2, Xiang Ren
1, Lisong Shi
1,
Xin Tu
1, Qing Kenneth Wang
1,3,* and An-Yuan Guo
2,*
1Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and
Technology and Center for Human Genome Research, Huazhong University of Science and Technology,
2Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Systems Biology, College of Life
Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China and
3Center for Cardiovascular Genetics, Cleveland Clinic, Cleveland, OH, USA
Received August 10, 2010; Revised October 16, 2010; Accepted October 18, 2010
ABSTRACT
Coronary artery disease (CAD) is a complex, multi-
factorial disease and a leading cause of mortality
world wide. Over the past decades, great efforts
have been made to elucidate the underlying
genetic basis of CAD and massive data have been
accumulated. To integrate these data together and
to provide a useful resource for researchers, we
developed the CADgene, a comprehensive
database for CAD genes. We manually extracted
CAD-related evidence for more than 300 candidate
genes for CAD from over 1300 publications of
genetic studies. We classified these candidate
genes into 12 functional categories based on their
roles in CAD. For each gene, we extracted detailed
information from related studies (e.g. the size of
case–control, population, SNP, odds ratio, P-value,
etc.) and made useful annotations, which include
general gene information, Gene Ontology annota-
tions, KEGG pathways, protein–protein interactions
and others. Besides the statistical number of
studies for each gene, CADgene also provides
tools to search and show the most frequently
studied candidate genes. In addition, CADgene
provides cumulative data from 11 publications of
CAD-related genome-wide association studies.
CADgene has a user-friendly web interface with
multiple browse and search functions. It is freely
available at http://www.bioguo.org/CADgene/.
INTRODUCTION
Coronary artery disease (CAD), also known as coronary
heart disease (CHD), is the most common cause of death
in the world. Many research efforts have been made to
identify its acquired and inherited risk factors (1). CAD
is a complex disease inﬂuenced by multiple combinations
of gene–gene and gene–environment interactions (2). The
heritability of CAD is estimated to be 40 to 60%, however
the underlying genetic mechanism is poorly understood
(3). CAD occurs when coronary arteries are narrowed or
occluded due to stenosis, which reduces or blocks the
blood supply through the diseased arteries to the heart.
The main cause of narrowing of the coronary artery is the
atherosclerotic plaque, while the main cause of the artery
occluding is the thrombus usually formed by atheroscler-
otic plaque rupture (4). There are many hypotheses
proposed to explain the underlying mechanisms of the ini-
tiation, progression and rupture of the coronary athero-
sclerotic plaque (5). The key points of these hypotheses
include: (i) lipoprotein retention; (ii) endothelial dysfunc-
tion; (iii) immune and inﬂammation response of the
artery; (iv) vascular smooth muscle cell (VSMC) prolifer-
ation; (v) lipid absorption by macrophage and VSMCs,
and the formation of foam cells; (vi) platelet activation
and thrombosis (4,6). It is challenging to explore the mo-
lecular mechanisms underlying the development of CAD.
A systematic CAD gene database will be a valuable and
essential resource for the research community.
Over the past decades, many experimental strategies
(genome-wide linkage scan, association studies, global
microarray gene expression analysis, proteomics, etc.)
and large efforts have been applied onto the studies
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didate genes and risk factors were implicated in increasing
the susceptibility of CAD (7). However, most of the
variants and genes have not been established consistently.
The most robust genetic risk variant for CAD was
identiﬁed on chromosome 9p21.3 by genome-wide associ-
ation studies (GWAS) (8). As case–control association
studies are widely used to identify susceptibility genes, a
large number of candidate gene association studies for
CAD were published and massive data has been
accumulated. Although the results of some studies
conﬂict with others, these ﬁndings did provide important
clues to explore the mechanisms in the pathogenesis of
CAD. Genes involved in different pathways and functions
such as altered lipoprotein handling, disruption in endo-
thelial integrity, arterial inﬂammation and thrombosis
were found to be related to CAD (9). In recent years, as
the cost of the high-throughput genotyping decreased
rapidly, GWAS are becoming a popular and powerful
approach to identify candidate variants for a speciﬁc
phenotype or disease. Several GWAS for CAD and myo-
cardial infarction (MI) have been conducted, and
identiﬁed many CAD-associated variants (10,11). Thus,
these data provide an unprecedented opportunity to con-
struct a useful gene resource for CAD, which can integrate
and analyze these data to explore the pathogenesis of
CAD. To date, a few databases for cardiovascular
diseases have been developed, such as the Cardio
database (12), inherited arrhythmias database (http://
www.fsm.it/cardmoc/), CaGE (13) and HuGE Navigator
Phenopedia (14). However, none of them are speciﬁc to
CAD, the most common cardiovascular disease. Some of
these databases were not updated for >5 years or even not
available at the present time.
Here we present a database for CAD genes (CADgene,
http://www.bioguo.org/CADgene/). Aiming to efﬁciently
integrate and analyze all or most of the published
CAD-related gene studies, we collected CAD candidate
genes and their detailed evidence associated with CAD
from publications (SNPs, P-value, odds ratio, etc.). For
each gene, we made useful annotations, which include
basic gene information (ID, name, alias, location etc.),
Gene Ontology (GO) annotation (15), KEGG pathway
(16) and protein–protein interaction (PPI) information.
In this work, we took advantage of the current
CADgene data and made some interesting statistical
analyses and discussions. CADgene seeks to be a useful
resource for the research communities of CAD and other
cardiovascular diseases.
DATA SOURCES AND METHODS
Data collection and curation
Currently, CADgene database contains >300 CAD-
related genes and their detailed information associated
with CAD from >1300 CAD-related publications pub-
lished before 20 June 2010. To obtain a complete list of
publications for CAD genes, we made a comprehensive
search for CAD-related studies in NCBI PubMed. We
used the following search terms for PubMed searching.
(‘coronary artery disease’ [Title/Abstract] OR ‘coronary
heart disease’ [Title/Abstract]) AND (‘gene’ [Title/
Abstract] AND (‘association’ [Title/Abstract] OR ‘micro-
array’ [Title/Abstract] OR ‘expression’ [Title/Abstract]
OR ‘linkage’ [Title/Abstract] OR ‘proteomics’ [Title/
Abstract] OR ‘metabolism’ [Title/Abstract] OR
‘metabolomics’ [Title/Abstract] OR ‘metabonomics’
[Title/Abstract]))
As a result, we obtained >2000 CAD-related publica-
tions, most of which are candidate gene association studies
or replication studies of previous ﬁndings. After manually
scanning the abstracts of these articles, we excluded the
reviews and those that studied other diseases instead of
CAD. Finally, we retained 1300 publications which
studied CAD candidate variants or genes. We extracted
the CAD-related detailed information for the reported
CAD genes from the abstracts by manually reading and
curation. The extracted information from a CAD-related
article includes: population, case and control, study
subjects (gene, SNP, mutation, expression level, etc.),
phenotype (CAD or MI), main results and conclusion of
the publication. Since we aim to construct a CAD gene
database, we organized these data as gene-centered by
manually converting different gene names in publications
to the unique NCBI Entrez Gene ID (http://www.ncbi
.nlm.nih.gov/gene).
As GWAS is a powerful and unbiased strategy for iden-
tifying phenotype associated variants, it is necessary to
include the available GWAS data in our database. We
made a comprehensive search for GWAS of CAD and
MI, and obtained 11 publications. We carefully read the
full text of these GWAS publications and extracted the
signiﬁcant results. Since the associated SNPs may reside
in genic or intergenic regions, we organized the curated
GWAS data as SNP-centered instead of gene-centered as
used in candidate gene studies.
Functional categories
Based on the proposed mechanisms and pathways for
CAD as mentioned above, we classiﬁed genes from candi-
date gene studies in CADgene into 12 categories according
to their functions (Table 1). Except the ‘Others’ category,
all other 11 functional categories are relatively independ-
ent functional pathways related to the development of
atherosclerotic plaque or risk factors of CAD. For
example, the endothelial dysfunction has been considered
as the ﬁrst step toward atherosclerosis and a common link
of all cardiovascular risk factors (17); immune cells
dominate early atherosclerotic lesions and atherosclerosis
is considered as an inﬂammatory disease (18). The ‘Others’
category includes genes in other functions rather than in
the 11 categories. In our opinion, such classiﬁcation will
help users to browse and understand these data in the
CADgene database.
Gene and SNP annotation
Besides the collected evidence from the abstracts, we
provided as many annotations as possible for each gene
to facilitate the interpretation of the relation with CAD,
especially the annotations of GO, KEGG pathways and
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the central ID for cross linking and annotation. We down-
loaded the basic gene annotation ﬁles from NCBI FTP
site. We parsed the gene_info and gene2refseq ﬁles to
retrieve the basic gene information such as gene symbol,
name, chromosome, genetic location, gene type and refer-
ence sequence information. We obtained the GO annota-
tions for each gene from the gene2go ﬁle and downloaded
the gene pathway data from KEGG database. We
integrated the PPI information from both HPRD (19)
and BioGRID (20), the two largest PPI databases, and
then extracted the direct interactors for CAD candidate
proteins in CADgene. For SNPs, we also provide their
basic information including chromosomal location,
allele, host genes, etc.
DATABASE CONSTRUCTION AND WEB
INTERFACE
Database organization
We stored and managed all the data in MySQL, which is a
popular and open source database management system
widely used in bioinformatics and biomedical database
development. Since candidate gene association studies
and GWAS have different data formats and contents,
we managed these data by separate tables. The article in-
formation, CAD gene evidence extracted from publica-
tions, basic gene information, reference sequences, GO
annotations, KEGG pathways and PPIs were stored into
individual tables.
Data browse
A user-friendly web interface was designed and imple-
mented for CADgene. It is freely available at http://
www.bioguo.org/CADgene/. Users can browse or search
all the data at different levels.
To help users to browse the data conveniently,
CADgene provides three different methods for browsing
CAD-related genes from candidate gene studies: (i) by
functional category; (ii) by chromosome; or (iii) through
a summary page which lists all the genes and the summary
of their CAD-related studies. A cascading style is applied
for data browsing, e.g. from functional category to gene
list, and then to gene information (Figure 1). Selecting a
functional category will list the CAD candidate genes in
this category (Figure 1A and B). When users click a gene
name on the gene list page, it will show the gene informa-
tion page, which contains the summarized information of
its CAD-related studies (e.g. author and year, population,
case and control, studied polymorphism number and
result assessment) and gene annotations (e.g. gene
symbol and name, GO annotations, RefSeq, database
cross links, KEGG pathways and PPIs) (Figure 1C–F).
CADgene provides the PPI information for each protein
by both a table list and an interaction network ﬁgure. By
clicking the hyperlink in the polymorphism column, it will
open the detailed page for the study that shows the
relation between the gene (SNP) and CAD (Figure 1G).
For GWAS data, we made a separate page to browse
them, which is similar with candidate gene browsing.
For further use of the data, we provided an advanced
browse tool for CADgene. On the advanced browse page,
users can browse data by combination of gene name with
the publication date or browse only the statistically sig-
niﬁcant or non-signiﬁcant studies for genes. Users may be
interested in those genes with multiple signiﬁcant studies.
Advanced browse page provides such a tool to view genes
by the number of their studies. To analyze the most fre-
quently studied genes, we designed a page to show the
statistical results of those genes with more than10 signiﬁ-
cant or nonsigniﬁcant studies. Additionally, users can
browse genes or SNPs identiﬁed in both candidate gene
studies and GWAS, which may serve as important links
between the two kinds of studies.
Data search
CADgene provides three approaches for searching the
data, including the text search and sequence search.
First, users may ﬁnd a quick search box on the top right
of each page for searching by gene ID or symbol or SNP
id. Second, CADgene provides an advanced search page,
on which users may search data through the gene name,
SNP ID, chromosomal locus, article information or gene
annotation. Additionally, we provide a batch search
function for a gene list on this page. Third, a BLAST
search against the nucleotide or protein sequences of the
CAD-related genes is also available in CADgene.
DISCUSSION
The study history of CAD genes
As CADgene contains most of the CAD-related associ-
ation studies, we roughly summarized the research
history of CAD genes by the number of publications
and published date (Supplementary Table S1). The
earliest study collected in CADgene was published in
1988. Genes encoding apolipoproteins were ﬁrst shown
to be associated with CAD and the lipoprotein metabol-
ism is still the research hotspot for CAD. All the nine
studies published before 1990 in CADgene were studies
of apolipoproteins (APOA1, APOC3 and APOB). Then,
genes in the rennin–angiotensin system (RAS) and
Thrombosis categories began to be studied and thereafter
Table 1. Summary of functional categories in CADgene
Functional category Number of
genes
Number of
articles
Lipid and lipoprotein metabolism 53 398
Immune and inﬂammation 68 173
RAS 11 152
Endothelial integrity 31 134
Thrombosis 26 120
Oxidation–reduction state 22 97
Homocysteine metabolism 7 71
Metalloproteinase and ECM 11 24
Gender difference 6 24
Glucose metabolism 8 17
VSMC abnormalities 7 7
Others 68 84
Nucleic Acids Research, 2011,Vol.39, Database issue D993Figure 1. Examples of the cascading browse and gene information in CADgene. (A) Functional categories in CADgene. (B) Gene list for the RAS
functional category. (C) CAD-related studies for a speciﬁc gene (i.e. AGTR1). (D) GO and KEGG annotations. (E) PPI information in a table.
(F) Graphic show of the PPI network. (G) Detailed information of a CAD-related study.
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2000, the CAD studies developed rapidly and 80%
studies in CADgene were published in the recent 10
years. Lipid and Lipoprotein Metabolism, Immune and
Inﬂammation and RAS are the top three studied function-
al categories for CAD. Studies for genes in the top six
functional categories account for >80% of all the
studies in CADgene (Supplementary Table S1). In the
recent 5 years (2006–2010), the studies of Immune and
Inﬂammation, and Endothelial Integrity categories were
developed quickly. CAD has been considered as a
disease of immune and inﬂammation (21), and endothe-
lium dysfunction has been considered as the ﬁrst step
toward CAD (17).
Most popular studied genes
To show the most popularly studied CAD genes,
CADgene provides a web page to show them (http://
www.bioguo.org/CADgene/topGenes.php). The hottest
gene is ACE (angiotensin I converting enzyme), a gene
in the RAS category, which has more than100 studies in
total. There are 25 genes with more than 10 signiﬁcant
studies and ﬁve of them also have more than 10
non-signiﬁcant studies. Because CAD is inﬂuenced by
multiple genetic and environmental factors, studies with
different cases and populations may obtain different
results for various pathogenesis. These 25 genes are
distributed in eight functional categories and 11 of them
are genes in the Lipid and Lipoprotein Metabolism
category, which includes ﬁve apolipoproteins (APOE,
APOB, APOA5, APOC3 and APOA1).
KEGG pathway and PPI
CAD is a complex disease and there may be huge biologic-
al networks and pathways contributing to the pathogen-
esis of CAD. So we provided the KEGG pathway and PPI
information for genes in CADgene.
For each candidate gene, CADgene displays its involved
KEGG pathways and all the CAD-related genes in these
pathways. As a result, 155 and 115 KEGG pathways
contain at least one and two genes in CADgene, respect-
ively, which reﬂects the complexity of CAD. Pathways
playing important roles in the pathogenesis of CAD are
at the top enriched pathway list, such as cytokine–
cytokine receptor interaction (22), complement and co-
agulation cascades (23), PPAR signaling pathway (24),
MAPK signaling pathway (25) and focal adhesion (22)
containing 29, 25, 17, 16 and 12 CAD-related genes, re-
spectively (Supplementary Table S2). We suggest that
more attention should be paid to the pathways containing
multiple CAD-related genes, and also genes involving
many pathways because they may act as linkers of these
pathways.
In addition to the pathway information of CAD-related
genes, CADgene also provides the direct interactors of
CAD proteins and their graphic PPI networks. For each
protein, we summarized the numbers of its interactors in
CADgene and in the human interactome, and the ratio of
them. We are interested in the top 21 proteins which have
no less than three interactors in CADgene and >50% of
their interactors are in CADgene gene list (Supplementary
Table S3). For example, ACE is the most studied gene for
CAD and all its interactors (AGTR2, BDKRB2 and
COMT) are in CADgene with CAD-related studies. We
also examined the enriched pathways for interactors of
each protein in CADgene. We are interested in the nine
proteins accompanied by ﬁve or more CAD-related
interactors in a speciﬁc pathway and listed them in
Supplementary Table S4. Five of the nine enriched
pathways are the complement and coagulation cascades
pathway, which may suggest its importance in CAD.
The protein encoded by the gene F2 (also known as co-
agulation factor II, prothrombin) has 45 interactors
totally and 17 of them are CAD-related proteins in
CADgene. Among the 17 interactors, 14 are involved in
the complement and coagulation cascades pathway. Thus,
the gene F2 should be very important in the complement
and coagulation cascades pathway and in the
CAD-related network. Although the gain-of-function F2
G20210A mutation was proved to be involved in the de-
velopment of venous thrombosis (26), which may suggest
its importance in the complement and coagulation
cascades pathway. However, gene F2 was just reported
to be associated with CAD at a modest risk (OR=1.3)
in a large meta-analysis, but not in single studies (2,27).
Further powerful studies are expected to ascertain its as-
sociation with CAD.
FUTURE PERSPECTIVES
CADgene is our ﬁrst gene database for cardiovascular
diseases aiming to provide a complete and up-to-date
gene resource to the research community. We will
continue collecting CAD-related association and GWAS
data regularly. On the other hand, since there are many
overlaps on the deﬁnitions and pathogeneses of some car-
diovascular diseases, especially for CAD, MI and athero-
sclerosis, we plan to construct a comprehensive gene
database for the main cardiovascular diseases and
develop more tools to utilize the data conveniently in
the future.
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